Literature DB >> 458554

Estimation of tissue-to-plasma partition coefficients used in physiological pharmacokinetic models.

H S Chen, J F Gross.   

Abstract

An important parameter in the development of pharmacokinetic models is the ratio of tissue drug concentration to the concentration of the drug in the arterial plasma or the effluent plasma. The relationship between these two tissue/plasma ratios is derived analytically for different routes of drug administration. The two are equal only in compartments with no elimination when the drug is infused at constant rate. For other routes of administration, the two ratios are identical in all compartments only when there is no elimination process. The tissue/plasma concentration ratios for infusion equilibrium are not equal to the corresponding values for the postdistribution phase after an intravenous bolus injection. When the plasma concentration for infusion and injection are the same, more drug will appear in the lung during infusion steady state than during the postdistribution equilibrium. The reverse is true for the other organs. The importance of properly defining the tissue/plasma ratio and its implication for pharmacokinetic modeling are discussed. The results may have important therapeutic implications for the availability of drugs using different routes of administration.

Mesh:

Substances:

Year:  1979        PMID: 458554     DOI: 10.1007/bf01059446

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  17 in total

1.  In vitro-in vivo correlation of drug metabolism--deamination of 1- -D-arabinofuranosylcytosine.

Authors:  R L Dedrick; D D Forrester; D H Ho
Journal:  Biochem Pharmacol       Date:  1972-01       Impact factor: 5.858

2.  Animal scale-up.

Authors:  R L Dedrick
Journal:  J Pharmacokinet Biopharm       Date:  1973-10

3.  Methotrexate pharmacokinetics.

Authors:  K B Bischoff; R L Dedrick; D S Zaharko; J A Longstreth
Journal:  J Pharm Sci       Date:  1971-08       Impact factor: 3.534

4.  Thiopental pharmacokinetics.

Authors:  K B Bischoff; R L Dedrick
Journal:  J Pharm Sci       Date:  1968-08       Impact factor: 3.534

5.  Effect of mode of administration on drug distribution in a two-compartment open system.

Authors:  M Gibaldi
Journal:  J Pharm Sci       Date:  1969-03       Impact factor: 3.534

6.  Studies on drug resistance. I. Distribution of l-beta-D-arabinofuranosylcytosine, cytidine and deoxycytidine in mice bearing ara-C-sensitive and-resistant P815 neoplasms.

Authors:  K Uchida; W Kreis
Journal:  Biochem Pharmacol       Date:  1969-05       Impact factor: 5.858

7.  Lidocaine disposition kinetics in monkey and man. I. Prediction by a perfusion model.

Authors:  N Benowitz; F P Forsyth; K L Melmon; M Rowland
Journal:  Clin Pharmacol Ther       Date:  1974-07       Impact factor: 6.875

8.  Pharmacokinetic model for salicyclate in cerebrospinal fluid, blood, organs, and tissues.

Authors:  C N Chen; D L Coleman; J D Andrade; A R Temple
Journal:  J Pharm Sci       Date:  1978-01       Impact factor: 3.534

9.  Enhancement by tetrahydrouridine of 1-beta-D-arabinofuranosylcytosine (cytarabine) oral activity in L1210 leukemic mice.

Authors:  G L Neil; T E Moxley; R C Manak
Journal:  Cancer Res       Date:  1970-08       Impact factor: 12.701

10.  A model for the kinetics of distribution of actinomycin-D in the beagle dog.

Authors:  R J Lutz; W M Galbraith; R L Dedrick; R Shrager; L B Mellett
Journal:  J Pharmacol Exp Ther       Date:  1977-03       Impact factor: 4.030

View more
  31 in total

1.  Prediction of in vivo tissue distribution from in vitro data. 3. Correlation between in vitro and in vivo tissue distribution of a homologous series of nine 5-n-alkyl-5-ethyl barbituric acids.

Authors:  Peter Ballard; David E Leahy; Malcolm Rowland
Journal:  Pharm Res       Date:  2003-06       Impact factor: 4.200

Review 2.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Kinetic modeling of ouabain tissue distribution based on slow and saturable binding to Na,K-ATPase.

Authors:  H Harashima; M Mamiya; M Yamazaki; Y Sawada; T Iga; M Hanano; Y Sugiyama
Journal:  Pharm Res       Date:  1992-12       Impact factor: 4.200

4.  Development of a whole body physiologically based model to characterise the pharmacokinetics of benzodiazepines. 1: Estimation of rat tissue-plasma partition ratios.

Authors:  Ivelina Gueorguieva; Ivan A Nestorov; Susan Murby; Sophie Gisbert; Brent Collins; Kelly Dickens; Judith Duffy; Ziad Hussain; Malcolm Rowland
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-08       Impact factor: 2.745

5.  Discrepancies in pharmacokinetic parameter estimation between bolus and infusion studies in the perfused rat hindlimb.

Authors:  A C Heatherington; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1995-10

6.  An understanding of flow- and diffusion-limited vs. carrier-mediated hepatic transport: a simulation study.

Authors:  W P Geng; K Poon; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1995-08

Review 7.  Physiologically based pharmacokinetic models for anticancer drugs.

Authors:  H S Chen; J F Gross
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

8.  A semiparametric approach to physiological flow models.

Authors:  D Verotta; L B Sheiner; W F Ebling; D R Stanski
Journal:  J Pharmacokinet Biopharm       Date:  1989-08

9.  Enantioselective tissue distribution of the basic drugs disopyramide, flecainide and verapamil in rats: role of plasma protein and tissue phosphatidylserine binding.

Authors:  K Hanada; S Akimoto; K Mitsui; K Mihara; H Ogata
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

10.  Human subcutaneous tissue distribution of fluconazole: comparison of microdialysis and suction blister techniques.

Authors:  Lucy Sasongko; Kenneth M Williams; Richard O Day; Andrew J McLachlan
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.